-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Microbot Medical, Lowers Price Target to $3

Benzinga·11/19/2026 15:58:46
Listen to the news
B. Riley Securities analyst Anderson Schock maintains Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $4 to $3.